Does dose of GnRH agonist ( nafarelin acetate ) affect intrafollicular PAPP-A expression in controlled ovarian hyperstimulation cycle?
The dose of GnRHa may have an impact on the intrafollicular environment of dominant follicles in COH cycles.
Co-administration of liraglutide 1.8 mg at steady state and insulin detemir produces an additive glucose-lowering effect without affecting the PK profile of either therapeutic agent suggesting that the addition of insulin detemir to patients treated with liraglutide will not require titration algorithms different from when insulin is added to OADs. The co-administration of insulin detemir and liraglutide was well tolerated.